OTCMKTS:CSLLY CSL (CSLLY) Stock Forecast, Price & News $102.46 +0.18 (+0.18%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$102.15▼$102.7050-Day Range$94.84▼$103.2852-Week Range$83.30▼$110.25Volume21,776 shsAverage Volume27,212 shsMarket Capitalization$98.85 billionP/E RatioN/ADividend Yield0.95%Price TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileAnalyst RatingsChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest CSL MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.43Based on 2 Articles This WeekInsider TradingN/AProj. Earnings Growth26.57%From $2.71 to $3.43 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.49 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for CSL. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of CSL have been sold short.Short Interest Ratio / Days to CoverCSL has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CSL has recently increased by 18,500.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.8 Dividend Strength Dividend YieldCSL has a dividend yield of 0.95%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCSL does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, CSL will have a dividend payout ratio of 28.28% next year. This indicates that CSL will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CSLLY. Previous Next 1.4 News and Social Media Coverage News SentimentCSL has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for CSL this week, compared to 3 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CSL insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.06% of the stock of CSL is held by institutions. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for CSL are expected to grow by 26.57% in the coming year, from $2.71 to $3.43 per share.Price to Book Value per Share RatioCSL has a P/B Ratio of 6.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About CSL (OTCMKTS:CSLLY) StockCSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring and CSL Seqirus. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The CSL Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.Read More Receive CSLLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address CSLLY Stock News HeadlinesJune 1, 2023 | msn.comThe CSL share price leapt higher in May. What’s next?May 31, 2023 | afr.comSCF Containers acquires Kiwi player CSL ContainersJune 4, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 27, 2023 | americanbankingnews.comCSL Limited (OTCMKTS:CSLLY) Short Interest UpdateMay 14, 2023 | msn.com4 ASX companies that own CSL shares (and lots of them!)May 12, 2023 | msn.comArcturus raised to Buy at H.C. Wainwright on prospects for COVID shotMay 12, 2023 | bizjournals.com2023 Life Sciences Awards: CSL SeqirusMay 3, 2023 | afr.comThe three things CSL’s new CEO now has to get rightJune 4, 2023 | Legacy Research (Affiliate) (Ad)“One-Stock Millionaire” IGNORES 99.9% of the MarketDuring the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.May 3, 2023 | afr.comCSL - Australia’s improbable global success storyMay 3, 2023 | msn.comCan the CSL share price crack a new, all-time high in 2023?May 3, 2023 | afr.comHow CSL became Australia’s third-largest companyMay 2, 2023 | afr.comThe COVID-19 jackpot that eluded CSLMay 2, 2023 | fool.com.auWhy did the CSL share price smash the ASX 200 in April?April 30, 2023 | afr.comHow CSL went from ‘bloated bureaucracy’ to $145b global behemothApril 5, 2023 | msn.comThe record interim CSL dividend is being paid today. How much is it?April 4, 2023 | americanbankingnews.comJefferies Financial Group Analysts Lift Earnings Estimates for CSL Limited (OTCMKTS:CSLLY)April 1, 2023 | fool.com.auDoes the CSL share price fall finally make it a no-brainer buy?March 29, 2023 | nasdaq.comCSL January 2024 Options Begin TradingMarch 29, 2023 | afr.comJPMorgan desk peels off whopper $421m CSL tradeMarch 28, 2023 | msn.comCSL Opens Waltham Vaccine Research, Development FacilityMarch 28, 2023 | finanznachrichten.deVifor International AG (CSL Vifor): Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAVMarch 22, 2023 | msn.comBPD: man burglarizes CSL Plasma Center, sets fire to furnitureMarch 21, 2023 | msn.comDoes the CSL share price really offer 22% upside right now?March 15, 2023 | msn.comWatch How Quickly A BMW M4 CSL Laps The NurburgringMarch 15, 2023 | msn.comHere’s how much I’d need to invest in CSL shares to generate a $300 monthly incomeMarch 10, 2023 | nz.finance.yahoo.comThose who invested in CSL (ASX:CSL) five years ago are up 87%See More Headlines CSLLY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CSLLY Company Calendar Today6/03/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CSLLY CUSIPN/A CIK1274152 Webwww.csl.com.au Phone(139) 389-1911Fax61-3-9389-1434Employees30,000Year Founded1904Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$10.56 billion Price / Sales9.36 Cash Flow$3.04 per share Price / Cash Flow33.71 Book Value$15.13 per share Price / Book6.77Miscellaneous Outstanding Shares964,740,000Free FloatN/AMarket Cap$98.85 billion OptionableNot Optionable Beta0.70 Key ExecutivesPaul McKenzieChief Executive Officer, MD & DirectorJoy Carolyn LintonChief Financial OfficerAndrew NashChief Scientific Officer, SVP & Head-ResearchWilliam MezzanotteCMO, Executive VP, Head-Research & DevelopmentBill CampbellChief Commercial Officer & Executive VPKey CompetitorsVertex PharmaceuticalsNASDAQ:VRTXRegeneron PharmaceuticalsNASDAQ:REGNZoetisNYSE:ZTSGSKNYSE:GSKSanofiNASDAQ:SNYView All Competitors CSLLY Stock - Frequently Asked Questions Should I buy or sell CSL stock right now? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CSLLY shares. View CSLLY analyst ratings or view top-rated stocks. How have CSLLY shares performed in 2023? CSL's stock was trading at $97.54 on January 1st, 2023. Since then, CSLLY shares have increased by 5.0% and is now trading at $102.46. View the best growth stocks for 2023 here. Are investors shorting CSL? CSL saw a increase in short interest in May. As of May 15th, there was short interest totaling 18,600 shares, an increase of 18,500.0% from the April 30th total of 100 shares. Based on an average daily trading volume, of 50,200 shares, the short-interest ratio is currently 0.4 days. View CSL's Short Interest. Is CSL a good dividend stock? CSL (OTCMKTS:CSLLY) pays an annual dividend of $0.97 per share and currently has a dividend yield of 0.95%. Read our dividend analysis for CSLLY. What is CSL's stock symbol? CSL trades on the OTCMKTS under the ticker symbol "CSLLY." How do I buy shares of CSL? Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CSL's stock price today? One share of CSLLY stock can currently be purchased for approximately $102.46. How much money does CSL make? CSL (OTCMKTS:CSLLY) has a market capitalization of $98.85 billion and generates $10.56 billion in revenue each year. How many employees does CSL have? The company employs 30,000 workers across the globe. How can I contact CSL? CSL's mailing address is 45 Poplar Road, Parkville C3, 3052. The official website for the company is www.csl.com.au. The company can be reached via phone at (139) 389-1911, via email at bernard.ronchi@csl.com, or via fax at 61-3-9389-1434. This page (OTCMKTS:CSLLY) was last updated on 6/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.